L’Oréal patents protein biomarker analysis and skin diagnostics system for highly personalised skin care


Writing in its worldwide patent​​, L’Oréal stated the two-pronged system had been developed for use in a medical or retail atmosphere, offering outcomes on a digital gadget equivalent to a smartphone, pill or desktop laptop. These pores and skin development predictions may then both be used to mix energetic ingredient formulations focusing on the particular wants and predictions recognized or used to make suggestions on current merchandise to.

Sure biomarkers linked to ‘medical indicators of ageing’

Biomarker evaluation, L’Oréal stated, was an more and more used “non-invasive”​ option to measure varied protein concentrations within the pores and skin; a lot of which had been recognized as linked to medical indicators of ageing and responsiveness or non-responsiveness to sure energetic components like retinol. Biomarker FLG2, for instance, had been discovered to be correlated with medical indicators of shiny and tough pores and skin; the IDE biomarker with eye wrinkles; the LCN1 biomarker with lack of elasticity; and the YKL40 and TG3 biomarkers proven to point whether or not a topic could be attentive to retinol to enhance under-eye wrinkles – all indicated by way of medical research.

Nevertheless, L’Oréal wrote in its patent: “Regardless that these correlations have been decided, the biomarker evaluation system solely supplies uncooked protein focus data and doesn’t use these correlations. What’s desired are methods and strategies that use the biomarker focus data to enhance skincare product formulations to deal with predicted pores and skin traits.”

“What can be desired are methods and strategies that use the biomarker focus data to generate skincare product suggestions and to enhance such suggestions to deal with predicted pores and skin traits,” ​it added.


Please enter your comment!
Please enter your name here